Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.
Topic:
Diabetes and the Heart
Speaker:
Professor S. Jacob (Villingen, DE)
Professor N. Marx (Aachen, DE)
Professor F. Cosentino (Stockholm, SE)
Professor J. Deanfield (London, GB)
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly
Event:
ESC Congress 2018
Congress Presentation
About the speakers
Professor Stephan Jacob
Villingen (Germany)
8
presentations
0
follower
Professor Nikolaus Marx
RWTH University Hospital Aachen, Aachen (Germany)
46
presentations
10
followers
Professor Francesco Cosentino
Karolinska University Hospital, Stockholm (Sweden)
24
presentations
0
follower
Professor John Eric Deanfield
University College London, London (United Kingdom of Great Britain & Northern Ireland)
50
presentations
3
followers
2 more presentations in this session
Introduction - Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure.
Speaker: Professor F. Cosentino (Stockholm, SE)
Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?
Speaker: Professor N. Marx (Aachen, DE)
Access the full session
Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure
Speakers:
Professor S. Jacob, Professor N. Marx, Professor F. Cosentino, Professor J. Deanfield, Professor F. Cosentino...
About the event
ESC 365 is supported by
